Lifecore Biomedical
In Scott Miller's portfolio · Greenhaven Road Capital
Ticker LFCR
Still in the portfolio as of Q3 2026. Every quarter it shows up in a Greenhaven Road Capital 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q3 2026 | Reduce 10% | 2,868,881 | 14.6% |
| Q2 2026 | Reduce 10% | 3,190,769 | 10.9% |
| Q1 2026 | Reduce 4% | 3,537,573 | 9.1% |
| Q4 2025 | No change | 3,682,573 | 5.1% |
| Q3 2025 | No change | 3,694,832 | 4.0% |
| Q2 2025 | Add 2% | 3,694,832 | 10.3% |
| Q1 2025 | No change | 3,616,146 | 10.4% |
| Q4 2024 | Add 62% | 3,616,146 | 4.3% |
| Q3 2024 | Add 1% | 2,228,784 | 4.7% |
| Q2 2024 | Add 3% | 2,216,124 | 5.3% |
| Q1 2024 | Reduce 9% | 2,144,018 | 4.8% |
| Q4 2023 | Reduce 46% | 2,366,956 | 6.2% |
| Q3 2023 | Add 131% | 4,386,666 | 8.3% |
| Q2 2023 | Add 84% | 1,902,639 | 9.3% |
| Q1 2023 | Buy | 1,034,449 | 2.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.